News
FITY
0.0002
0.00%
0.0000
Weekly Report: what happened at FITY last week (0921-0925)?
Weekly Report · 4d ago
Weekly Report: what happened at FITY last week (0914-0918)?
Weekly Report · 09/21 10:07
Weekly Report: what happened at FITY last week (0907-0911)?
Weekly Report · 09/14 10:12
Weekly Report: what happened at FITY last week (0831-0904)?
Weekly Report · 09/07 10:06
Weekly Report: what happened at FITY last week (0824-0828)?
Weekly Report · 08/31 10:13
Weekly Report: what happened at FITY last week (0817-0821)?
Weekly Report · 08/24 10:13
Weekly Report: what happened at FITY last week (0810-0814)?
Weekly Report · 08/17 10:14
Weekly Report: what happened at FITY last week (0803-0807)?
Weekly Report · 08/10 10:09
Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform
Barchart · 08/07 08:00
Weekly Report: what happened at FITY last week (0727-0731)?
Weekly Report · 08/03 10:09
Weekly Report: what happened at FITY last week (0720-0724)?
Weekly Report · 07/27 10:13
Weekly Report: what happened at FITY last week (0713-0717)?
Weekly Report · 07/20 10:10
Weekly Report: what happened at FITY last week (0706-0710)?
Weekly Report · 07/13 10:11
Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth
Barchart · 07/10 09:00
Weekly Report: what happened at FITY last week (0629-0703)?
Weekly Report · 07/06 10:15
Weekly Report: what happened at FITY last week (0622-0626)?
Weekly Report · 06/29 10:10
Weekly Report: what happened at FITY last week (0615-0619)?
Weekly Report · 06/22 10:18
Weekly Report: what happened at FITY last week (0608-0612)?
Weekly Report · 06/15 10:19
Weekly Report: what happened at FITY last week (0601-0605)?
Weekly Report · 06/08 10:15
Weekly Report: what happened at FITY last week (0525-0529)?
Weekly Report · 06/01 10:19
More
Webull provides a variety of real-time FITY stock news. You can receive the latest news about Fifty 1 Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About FITY
Fifty 1 Labs, Inc. is a biotechnology and life sciences company. The Company focuses on peptide products, peptide discovery, AI-enabled research, and clinical development. It also focuses on peptide science, musculoskeletal health, sports performance, injury recovery, rehabilitation, and evidence-driven wellness. It owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies designed to enhance athletic performance, recovery, and overall health. It has acquired a musculoskeletal recovery product line. The product line includes five key product concepts designed to support the Company's peptide and musculoskeletal health markets. The portfolio includes natural health products focused on connective tissue recovery, inflammation support, post-surgical recovery nutrition, joint and cartilage support, and an investigational BPC-157-focused research platform.